首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1485739

活生物治疗产品和微生物 CDMO 市场，按服务类型、营运规模、应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Live Biotherapeutics Products & Microbe CDMO Market, By Service Type, By Scale of Operation, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年05月11日 | 出版商:

AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2023 年，活体生物治疗产品和微生物 CDMO 市场规模为 2,034 万美元，2024 年至 2032 年复合年增长率为 40.5%。

活体生物治疗产品与微生物 CDMO 市场-市场动态

推动下一代活性生物疗法和微生物组合同製造的研发计划

推动下一代活体生物疗法和微生物组合同製造的研发计画正在重塑治疗发展。例如，美国国立卫生研究院 (NIH) 为微生物组研究分配了大量资金，强调了其在医疗保健创新中的重要性。此外，Seres Therapeutics 和 Vedanta Biosciences 等领先的生物製药公司正在开拓新型活生物治疗候选药物，强调基于微生物组的疗法的潜力。学术机构和 CDMO 之间的合作，例如加州大学圣地牙哥分校与 SGI-DNA 之间在合成生物学解决方案方面的合作，展示了先进技术在以微生物组为中心的製造中的日益整合。这些努力强调了向具有广泛临床意义的个人化、微生物组标靶治疗的变革性转变。

活体生物疗法产品和微生物 CDMO 市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 40.5% 左右的复合年增长率成长

根据服务类型细分，预计製造服务将在 2023 年显示最大的市场份额

根据手术规模细分，临床规模手术是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

活体生物治疗产品与微生物 CDMO 市场-細項分析：

全球活体生物治疗产品和微生物 CDMO 市场根据服务类型、营运规模、应用和区域进行细分。

根据服务类型，市场分为两类：开发服务和製造服务。由于生产活性生物治疗产品对专业製造能力的迫切需求，消费者通常优先考虑製造服务而不是开发服务。高效且可扩展的製造流程对于基于微生物组的疗法的商业化和市场供应至关重要。

根据营运规模，市场分为三类：临床前规模营运、临床规模营运和商业规模营运。运营通常优先考虑临床规模运营，其次是商业规模运营，然后是临床前规模运营。临床规模营运对于推动产品开发走向监管审批和商业化至关重要，而商业规模运作则确保活体生物治疗药物的市场供应和可扩展性。

活体生物治疗产品和微生物 CDMO 市场 - 地理洞察

由于领先的製药和生物技术公司强劲的研发活动和对基于微生物组的疗法的投资，北美占据了显着的地位。欧洲紧随其后，建立了支持活体生物治疗和 CDMO 服务创新的监管框架。亚太地区展现出快速成长潜力，这归因于医疗保健支出的增加、先进生物技术的不断采用以及本地和国际参与者之间不断增长的合作伙伴关係。该地区的新兴经济体，特别是中国和印度等国家，正在见证以微生物组为重点的研究和开发的激增，从而促进了市场的扩张。

活生物治疗产品与微生物 CDMO 市场-竞争格局：

Lonza Group、Charles River Laboratories 和 Catalent 等主要参与者处于领先地位，为活性生物治疗药物的开发和製造提供全面的 CDMO 服务。 Seres Therapeutics 和 Vedanta Biosciences 在活体生物治疗产品领域处于领先地位，专注于针对各种适应症的基于微生物组的疗法。 Bacteria 和 Seres Therapeutics 等商业製造领域的合作凸显了透过合作来增强製造能力和扩大市场覆盖范围的趋势。 SBT Instruments 等新兴公司贡献创新技术，而老牌企业则投资研发，重新定义以微生物组为中心的疗法和合约製造服务的未来。这种竞争格局凸显了我们不断努力推动创新并满足对先进活性生物疗法产品和 CDMO 解决方案不断增长的需求。多家公司正在合作开发和生产创新的活体生物治疗药物。例如，2019 年 10 月，4D Pharma plc 宣布与默沙东、默克公司达成研究合作和授权协议，以发现和开髮用于疫苗的活生物治疗产品 (LBP)。

市场片段
- 按服务类型分類的活生物治疗产品和微生物 CDMO 市场片段
- 按营运规模分類的活体生物疗法产品和微生物 CDMO 市场片段
- 活生物治疗产品和微生物 CDMO 市场片段（按应用）
- 按国家/地区分類的活生物治疗产品和微生物 CDMO 市场片段
- 按地区分類的活生物疗法产品和微生物 CDMO 市场片段
竞争洞察

第 3 章：活生物治疗产品和微生物 CDMO 主要市场趋势

活生物治疗产品和微生物 CDMO 市场驱动因素
- 市场驱动因素的影响分析
活体生物治疗产品和微生物 CDMO 市场限制
- 市场限制影响分析
活体生物治疗产品和微生物 CDMO 市场机会
活体生物治疗产品与微生物 CDMO 市场未来趋势

第 4 章：活生物治疗产品与微生物 CDMO 产业研究

PEST分析
波特五力分析
成长前景图
规范架构分析

第 5 章：活生物治疗产品与微生物 CDMO 市场：COVID-19 影响分析

COVID-19 之前的影响分析
COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分

第 6 章：活体生物疗法产品与微生物 CDMO 市场格局

活体生物疗法产品和微生物 CDMO 市场份额分析，2023 年
按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析

第 7 章：活生物治疗产品和微生物 CDMO 市场 - 按服务类型

概述
- 按服务类型分類的细分市场占有率分析
- 开发服务
- 製造服务
- 其他的

第 8 章：活生物治疗产品和微生物 CDMO 市场 - 按营运规模

概述
- 按经营规模分類的细分市场占有率分析
- 临床前规模运营
- 临床规模运营
- 商业规模营运

第 9 章：活体生物疗法产品和微生物 CDMO 市场 - 按应用

概述
- 按应用分類的细分市场占有率分析
- 艰难梭菌
- 克罗恩病
- 肠躁症
- 糖尿病
- 其他的

第 10 章：活生物治疗产品和微生物 CDMO 市场 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美活体生物疗法产品和微生物 CDMO 主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按服务类型）
- 北美市场规模和预测（按营运规模）
- 北美市场规模和预测（按应用）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲活体生物治疗产品和微生物 CDMO 主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模和预测（按服务类型）
- 欧洲市场规模与预测（按营运规模）
- 欧洲市场规模和预测（按应用）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区活体生物疗法产品和微生物 CDMO 主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按服务类型）
- 按营运规模分類的亚太市场规模和预测
- 亚太地区市场规模与预测（按应用）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲活体生物治疗产品和微生物 CDMO 主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模和预测（按服务类型）
- 拉丁美洲市场规模与预测（按营运规模）
- 拉丁美洲市场规模与预测（按应用）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲活体生物疗法产品和微生物 CDMO 主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按服务类型）
- 中东和非洲市场规模及预测（按营运规模）
- 中东和非洲市场规模及预测（按应用）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 活体生物治疗产品和微生物 CDMO 产业

竞争仪表板
公司简介
- D Pharma PLC
- Catalent, Inc.
- Chr. Hansen Holding A/S
- Evelo Biosciences, Inc.
- Evonik Industries AG
- Ferring Pharmaceuticals
- Lonza Group AG
- Microbiotica Ltd.
- Pivot Bio
- Rebiotix, Inc. (a Ferring Pharmaceuticals company)
- Samsung Biologics
- Second Genome, Inc.
- Seres Therapeutics, Inc.
- Synlogic, Inc.
- Vedanta Biosciences, Inc.
- Wacker Chemie AG
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV2637

REPORT HIGHLIGHT

Live Biotherapeutics Products & Microbe CDMO Market size was valued at USD 20.34 million in 2023, expanding at a CAGR of 40.5% from 2024 to 2032.

The Live Biotherapeutics Products & Microbe CDMO market involves developing, manufacturing, and commercializing therapeutic products based on live microbes for medical applications. The increasing demand for microbiome-based therapies is driven by awareness of the microbiome's role in health, advancements in microbial engineering enabling customized therapeutics, and the rising prevalence of chronic diseases facilitating market entry. However, challenges such as the complexity of microbiome research, manufacturing scalability issues, safety concerns, and limited market understanding pose restraints on market growth. Opportunities lie in expanding therapeutic applications beyond gastrointestinal disorders, increased R&D investment in microbiome therapeutics, and personalized medicine approaches enhancing targeted treatment strategies in healthcare.

Live Biotherapeutics Products & Microbe CDMO Market- Market Dynamics

Advancing R&D Initiatives in Next-Generation Live Biotherapeutics and Microbiome Contract Manufacturing

Advancing R&D initiatives in next-generation live biotherapeutics and microbiome contract manufacturing are reshaping therapeutic development. For instance, the National Institutes of Health (NIH) has allocated significant funding towards microbiome research, highlighting its importance in healthcare innovation. Additionally, leading biopharmaceutical companies like Seres Therapeutics and Vedanta Biosciences are pioneering novel live biotherapeutic candidates, emphasizing the potential of microbiome-based therapies. Collaborations between academic institutions and CDMOs, such as the partnership between the University of California, San Diego, and SGI-DNA for synthetic biology solutions, showcase the growing integration of advanced technologies in microbiome-focused manufacturing. These efforts underscore a transformative shift towards personalized, microbiome-targeted therapeutics with broad clinical implications.

Live Biotherapeutics Products & Microbe CDMO Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.5% over the forecast period (2024-2032)

Based on Service Type segmentation, Manufacturing Services was predicted to show maximum market share in the year 2023

Based on the Scale of Operation segmentation, Clinical Scale Operations was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Live Biotherapeutics Products & Microbe CDMO Market- Segmentation Analysis:

The Global Live Biotherapeutics Products & Microbe CDMO Market is segmented based on Service Type, Scale of Operation, Application, and Region.

The market is divided into two categories based on Service Type: Development Services and Manufacturing Services. Consumers typically prioritize Manufacturing Services over Development Services due to the critical need for specialized manufacturing capabilities in producing live biotherapeutic products. Efficient and scalable manufacturing processes are essential for the commercialization and market supply of microbiome-based therapies.

The market is divided into three categories based on Scale of Operation: Preclinical Scale Operations, Clinical Scale Operations, and Commercial Scale Operations. Operations typically prioritize Clinical Scale Operations followed by Commercial Scale Operations and then Preclinical Scale Operations. Clinical scale operations are critical for advancing product development towards regulatory approval and commercialization, while commercial scale operations ensure market supply and scalability of live biotherapeutics.

Live Biotherapeutics Products & Microbe CDMO Market- Geographical Insights

North America holds a prominent position, driven by robust R&D activities and investments in microbiome-based therapies by leading pharmaceutical and biotechnology companies. Europe follows closely, with established regulatory frameworks supporting innovation in live biotherapeutics and CDMO services. Asia Pacific showcases rapid growth potential, attributed to increasing healthcare expenditure, rising adoption of advanced biotechnology, and growing partnerships between local and international players. Emerging economies in this region, particularly in countries like China and India, are witnessing a surge in microbiome-focused research and development, contributing to market expansion.

Live Biotherapeutics Products & Microbe CDMO Market- Competitive Landscape:

Key players like Lonza Group, Charles River Laboratories, and Catalent are at the forefront, offering comprehensive CDMO services for live biotherapeutics development and manufacturing. Seres Therapeutics and Vedanta Biosciences lead in live biotherapeutics products, focusing on microbiome-based therapies for various indications. Collaborations such as Bacteria and Seres Therapeutics for commercial manufacturing highlight the trend towards partnerships to enhance manufacturing capabilities and expand market reach. Emerging companies like SBT Instruments contribute innovative technologies, while established players invest in R&D to redefine the future of microbiome-focused therapies and contract manufacturing services. This competitive landscape underscores ongoing efforts to drive innovation and meet the growing demand for advanced live biotherapeutic products and CDMO solutions. Several companies are collaborating for the development and production of innovative live biotherapeutics. For instance, in October 2019, 4D Pharma plc announced a research collaboration and licensing agreement with MSD, Merck & Co., Inc., to discover and develop Live Biotherapeutic Products (LBPs) for vaccines.

Recent Developments:

In June 2023, Biose Industrie and SBT Instruments collaborated to integrate rapid viable cell counts into Biose's manufacturing, setting a new standard for microbe enumeration. This integration aims to expedite clinical trials and market approval for Biose's live biotherapeutic products.

In November 2021, Bacthera and Seres Therapeutics are collaborating to manufacture SER-109, Seres' lead product candidate for recurrent Clostridioides difficile infection (CDI). Bacthera is establishing a dedicated commercial manufacturing facility within its new Microbiome Center of Excellence located on Lonza's Ibex campus in Visp, Switzerland.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

4D Pharma PLC

Catalent, Inc.

Chr. Hansen Holding A/S

Evelo Biosciences, Inc.

Evonik Industries AG

Ferring Pharmaceuticals

Lonza Group AG

Microbiotica Ltd.

Pivot Bio

Rebiotix, Inc. (a Ferring Pharmaceuticals company)

Samsung Biologics

Second Genome, Inc.

Seres Therapeutics, Inc.

Synlogic, Inc.

Vedanta Biosciences, Inc.

Wacker Chemie AG

Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Development Services
Manufacturing Services
Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SCALE OF OPERATION- MARKET ANALYSIS, 2019 - 2032

Preclinical Scale Operations
Clinical Scale Operations
Commercial Scale Operations

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

C.difficle
Crohn's disease
IBS
Diabetes
Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Live Biotherapeutics Products & Microbe CDMO Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Service Type
- 2.1.2.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Scale of Operation
- 2.1.3.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Application
- 2.1.4.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Country
- 2.1.5.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Region
2.2.Competitive Insights

3.Live Biotherapeutics Products & Microbe CDMO Key Market Trends

3.1.Live Biotherapeutics Products & Microbe CDMO Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Live Biotherapeutics Products & Microbe CDMO Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Live Biotherapeutics Products & Microbe CDMO Market Opportunities
3.4.Live Biotherapeutics Products & Microbe CDMO Market Future Trends

4.Live Biotherapeutics Products & Microbe CDMO Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Live Biotherapeutics Products & Microbe CDMO Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Live Biotherapeutics Products & Microbe CDMO Market Landscape

6.1.Live Biotherapeutics Products & Microbe CDMO Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Live Biotherapeutics Products & Microbe CDMO Market - By Service Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 7.1.2.Development Services
- 7.1.3.Manufacturing Services
- 7.1.4.Others

8.Live Biotherapeutics Products & Microbe CDMO Market - By Scale of Operation

8.1.Overview
- 8.1.1.Segment Share Analysis, By Scale of Operation, 2023 & 2032 (%)
- 8.1.2.Preclinical Scale Operations
- 8.1.3.Clinical Scale Operations
- 8.1.4.Commercial Scale Operations

9.Live Biotherapeutics Products & Microbe CDMO Market - By Application

9.1.Overview
- 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2.C.difficle
- 9.1.3.Crohns disease
- 9.1.4.IBS
- 9.1.5.Diabetes
- 9.1.6.Others

10.Live Biotherapeutics Products & Microbe CDMO Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Live Biotherapeutics Products & Microbe CDMO Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.4D Pharma PLC
- 11.2.2.Catalent, Inc.
- 11.2.3.Chr. Hansen Holding A/S
- 11.2.4.Evelo Biosciences, Inc.
- 11.2.5.Evonik Industries AG
- 11.2.6.Ferring Pharmaceuticals
- 11.2.7.Lonza Group AG
- 11.2.8.Microbiotica Ltd.
- 11.2.9.Pivot Bio
- 11.2.10.Rebiotix, Inc. (a Ferring Pharmaceuticals company)
- 11.2.11.Samsung Biologics
- 11.2.12.Second Genome, Inc.
- 11.2.13.Seres Therapeutics, Inc.
- 11.2.14.Synlogic, Inc.
- 11.2.15.Vedanta Biosciences, Inc.
- 11.2.16.Wacker Chemie AG
- 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

13.1.Research Methodology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Service Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Service Type
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Service Type 2019-2032 (USD Million)
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Scale of Operation Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Scale of Operation
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation 2019-2032 (USD Million)
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Application 2019-2032 (USD Million)
TABLE Live Biotherapeutics Products & Microbe CDMO Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Region 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)